The new funding will help the cluster build on initial milestones and to prepare for clinical applications, particularly in cancer.
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies today announced the expansion of its Compatible Products Programme (CPP), welcoming a new cohort of leading partners whose products now ...
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, today announced a new collaboration with UK ...
Nanopore sequencing offers comparable accuracy to short-read NGS for IGH clonotyping in CLL, with advantages in cost and laboratory footprint. The study confirms reliable somatic hypermutation status ...
Cell and gene therapies are rapidly becoming a staple of the therapeutic landscape for a range of diseases. Recent improvements in the accuracy, read length, and throughput offered by Oxford Nanopore ...
With any-length reads of DNA and RNA, from short to ultra-long, you can finally characterize the full diversity of our microbial world. In this White Paper, find out how nanopore sequencing is ...
Funding from agencies such as the National Science Foundation, the National Institutes of Health, NASA and many more help ensure the United States remains at the forefront of discoveries in health, ...
Following on from the recent official launch of BGI’s new CycloneSEQ™ is the first independently reviewed benchmarking data. The CycloneSEQ™ platform delivers long-reads using novel nanopore ...
Detailed price information for Oxford Nanopore Tech Plc (ONTTF) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results